Share your videos with the world

As breakthroughs in cancer treatments are occurring at an ever increasing rate, The Leukemia & Lymphoma Society (LLS) is shining a spotlight on the women in science who are helping to lead these advances. Through its significant investment in cancer research – more than $1.2 billion since its founding nearly 70 years ago – LLS is committed to funding and recognizing female scientists, physicians, social workers and nurses, and encouraging young women to participate in STEM (science, technology, engineering and math) education and pursue careers in the sciences. To view the multimedia release go to: https://www.multivu.com/players/English/8128552-lls-women-in-science/

With or without a working knowledge of cannabis, most dispensary consumers have a speaking acquaintance with the compounds THC and CBD. But scientists are flirting with lesser known kinfolk in the cannabinoid family, compounds which are for the most part non-psychoactive but have intriguing potential health benefits. One such cannabinoid is Cannabinol, known in the industry as CBN. CBN is a non-psychoactive cannabinoid that is a breakdown product of the cannabis superstar tetrahydrocannabinol (THC), the plant’s most abundant constituent best known for the plant’s psychoactive “high.” As the THC in cannabis buds ages, it transforms into cannabinol through a process known as oxidation. To view the multimedia release go to: https://www.multivu.com/players/English/8308957-gb-sciences-cannabis-brain-nurse-discusses-cbd-and-cbn/